An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202583
Company: RISING

Products on ANDA 202583

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CROMOLYN SODIUM	CROMOLYN SODIUM	100MG/5ML	CONCENTRATE;ORAL	Prescription	AA	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202583

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/27/2011	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202583s000ltr.pdf

Therapeutic Equivalents for ANDA 202583

CROMOLYN SODIUM

CONCENTRATE;ORAL; 100MG/5ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CROMOLYN SODIUM	CROMOLYN SODIUM	100MG/5ML	CONCENTRATE;ORAL	Prescription	No	AA	209264	AILEX PHARMS LLC
CROMOLYN SODIUM	CROMOLYN SODIUM	100MG/5ML	CONCENTRATE;ORAL	Prescription	No	AA	202745	MICRO LABS LTD INDIA
CROMOLYN SODIUM	CROMOLYN SODIUM	100MG/5ML	CONCENTRATE;ORAL	Prescription	No	AA	202583	RISING
GASTROCROM	CROMOLYN SODIUM	100MG/5ML	CONCENTRATE;ORAL	Prescription	Yes	AA	020479	MYLAN SPECIALITY LP

Top